[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ByMadeleineA Avatar @ByMadeleineA Madeleine Armstrong

Madeleine Armstrong posts on X about $azn, $pfe, $dsnky, $gild the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXXX% currencies #4057

Social topic influence $azn #9, $pfe #149, $dsnky #1, $gild #26, $dskny #1, has been 5.88%, $rhhby #15, $arvn #5, $lly #168, $gsks #1

Top accounts mentioned or mentioned by @apexonco @houndcl @amylucio2009 @sanctuarybio @sanctuary_bio @bioinvestor24 @biotwit1 @banana_oncology @avidresearch @jacobplieth @savoryseaw50174 @pdufa_pulse

Top assets mentioned AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD) Arvinas, Inc (ARVN) Eli Lilly and Company (LLY) GSK plc (GSK) Novartis AG (NVS)

Top Social Posts #

Top posts by engagements in the last XX hours

"$PFE jumps straight from phase X to phase X with its EZH2 inhibitor mevrometostat. What could possibly go wrong Via @ApexOnco $IPN.PA $DSNKY $NVS"
X Link @ByMadeleineA 2024-08-19T12:27Z 8110 followers, 5589 engagements

"PFS curves with Trodelvy in Ascent-03 $GILD #ESMO25"
X Link @ByMadeleineA 2025-10-19T07:23Z 8108 followers, XXX engagements

"Am I reading this right That XX% 2L pancreatic ORR with vopimetostat came in X patients Why hasn't $TNGX provided a waterfall plot"
X Link @ByMadeleineA 2025-10-23T15:21Z 8115 followers, 14.5K engagements

"$AVBP looks for lung cancer white space with its EGFR inhibitor firmonertinib at #WCLC24. Via @ApexOnco"
X Link @ByMadeleineA 2024-09-09T16:32Z 8112 followers, 4394 engagements

"A study of $BNTX & $RHHBY's neoantigen project autogene cevumeran has quietly gone on hold"
X Link @ByMadeleineA 2025-07-10T11:41Z 8112 followers, 3046 engagements

"A hit with giredestrant in the ITT population but this seems key: "The trial has been enriched forESR1-mutated patients above the natural prevalence". Wondering how much the result was driven by ERS1 mutants $RHHBY"
X Link @ByMadeleineA 2025-09-22T07:09Z 8112 followers, 2058 engagements

"$AZN gives the PDUFA date for Enhertu + Perjeta in 1st-line HER2+ve as "Q1 2026" but $DSKNY is more specific: XX Jan (use based on Destiny-Breast09)"
X Link @ByMadeleineA 2025-09-24T08:35Z 8112 followers, 2959 engagements

"Compare the wording on OS from $AZN & $DSKNY on Tropion-Breast02 vs $GILD on Ascent-03. Datroway "stat sig & clinically meaningful" on both PFS & OS but only "no OS detriment" for Trodelvy"
X Link @ByMadeleineA 2025-10-06T08:24Z 8112 followers, 9454 engagements

"We were right about Tropion-Breast02 $AZN #ESMO25"
X Link @ByMadeleineA 2025-10-13T08:52Z 8112 followers, 5315 engagements

"$RHHY is out with oral SERD data ahead of its #ESMO25 presentation. The ITT result looks clearly driven by ESR1m pts; the question now is whether Roche has done enough to get a broad label $LLY $ARVN $PFE"
X Link @ByMadeleineA 2025-10-18T05:19Z 8111 followers, 4851 engagements

"Well these are the most promising signs I think we've seen in non-ESR1m pts with a SERD. And $RHHBY has been clever by enrolling XX% of pts in Evera with ESR1m. Now over to the FDA #ESMO25 $LLY $PFE $ARVN"
X Link @ByMadeleineA 2025-10-18T08:35Z 8111 followers, 1925 engagements

"Enhertus perioperative Destiny beckons but watch out for ILD. The @ApexOnco take on Destiny-Breast05 & Destiny-Breast11 data at #ESMO25 $AZN $DSKNY"
X Link @ByMadeleineA 2025-10-18T17:46Z 8112 followers, 3087 engagements

"Cross-trial comparison of Datroway vs Trodelvy in first-line TNBC at #ESMO25. $AZN & $DSNKY have the edge over $GILD (OS data immature with Trodelvy)"
X Link @ByMadeleineA 2025-10-19T06:51Z 8112 followers, 5769 engagements

"The #ESMO25 discussant Dr Ana Garrido-Castro weighs in on how to choose between Trodelvy & Datroway"
X Link @ByMadeleineA 2025-10-19T07:59Z 8112 followers, 1214 engagements

"Missed this at the time of the presentation as footnote is so small: X gr3 pneumonitis then death in Tropion-Breast02 was deemed related to disease $AZN $DSNKY #ESMO25"
X Link @ByMadeleineA 2025-10-19T09:44Z 8112 followers, 4135 engagements

"More info on Stellar-303 deaths #ESMO25"
X Link @ByMadeleineA 2025-10-20T07:39Z 8112 followers, 1145 engagements

"And another trial failure sneaked into Q2 earnings this time for $GSK's anti-TIM3 MAb cobolimab"
X Link @ByMadeleineA 2025-07-30T09:09Z 8115 followers, 5184 engagements

"eVOLVE-RCC02 paused after "potential immune-mediated adverse events" $RCUS $AZN"
X Link @ByMadeleineA 2025-10-29T09:19Z 8115 followers, 1698 engagements

"It's officially over for cobolimab although that's been on the cards for a while $GSK"
X Link @ByMadeleineA 2025-10-29T09:50Z 8115 followers, 2004 engagements

"As for $GSK's IDRx buy the second-line StrateGIST X trial of GSK6042981 has just been unveiled and a first-line trial is to start in 2026"
X Link @ByMadeleineA 2025-10-29T10:02Z 8115 followers, XXX engagements

"More $GSK discontinuations. As well as cobolimab GSK4381562 (anti-PVRIG) & nelistotug (anti-CD96) are also gone"
X Link @ByMadeleineA 2025-10-29T10:12Z 8115 followers, XXX engagements